AstraZeneca Sets Up Industrial Park In Shanghai
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca is planning to increase its investment in China by establishing an AstraZeneca industrial park in Shanghai. It will be a comprehensive center that combines highly efficient management activities, advanced R&D facilities and first-class training amenities. The project, which has started, will be completed by 2010. AstraZeneca's 2007 annual report showed that the company achieved $500 million sales in China (including Hong Kong), an increase of 25 percent over the previous year, even while its global profit decreased by 7.2 percent. (Click here for more - Chinese Language)